BlueRipple Health
Self-advocacy training for coronary artery disease. Walk into every appointment prepared. See the portal

Multivariable Mendelian Randomization Prioritizes ApoB as Key Lipid Risk Factor for Coronary Artery Disease

Verena Zuber, Dipender Gill, Mika Ala-Korpela · Mendelian randomization study

BlueRipple Assessment

Evidence Strength 88/100 · Strong
Clinical Significance 92/100 · Strong

The original source

Zuber V, Gill D, Ala-Korpela M, et al. High-throughput multivariable Mendelian randomization analysis prioritizes apolipoprotein B as key lipid risk factor for coronary artery disease. Int J Epidemiol. 2021;50(3):893–901.

Sample size: 453,595
View original →
ApoBLDL-CTriglyceridesMendelian RandomizationCoronary Artery DiseaseCausal Lipid Risk

← All journal research